China · Delayed Price · Currency is CNY Suzhou Highfine Biotech Statistics
Total Valuation
SHE:301393 has a market cap or net worth of CNY 6.27 billion. The enterprise value is 5.02 billion.
| Market Cap | 6.27B |
| Enterprise Value | 5.02B |
Important Dates
The next confirmed earnings date is Friday, April 17, 2026.
| Earnings Date | Apr 17, 2026 |
| Ex-Dividend Date | Nov 11, 2025 |
Share Statistics
SHE:301393 has 106.97 million shares outstanding. The number of shares has decreased by -0.76% in one year.
| Current Share Class | 106.97M |
| Shares Outstanding | 106.97M |
| Shares Change (YoY) | -0.76% |
| Shares Change (QoQ) | -1.40% |
| Owned by Insiders (%) | 58.51% |
| Owned by Institutions (%) | 4.50% |
| Float | 40.16M |
Valuation Ratios
The trailing PE ratio is 54.82.
| PE Ratio | 54.82 |
| Forward PE | n/a |
| PS Ratio | 10.41 |
| PB Ratio | 2.66 |
| P/TBV Ratio | 2.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 80.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.70, with an EV/FCF ratio of -37.75.
| EV / Earnings | 43.77 |
| EV / Sales | 8.33 |
| EV / EBITDA | 32.70 |
| EV / EBIT | 43.03 |
| EV / FCF | -37.75 |
Financial Position
The company has a current ratio of 7.08, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.08 |
| Quick Ratio | 6.28 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.33 |
| Debt / FCF | -0.39 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.79% and return on invested capital (ROIC) is 14.45%.
| Return on Equity (ROE) | 4.79% |
| Return on Assets (ROA) | 2.91% |
| Return on Invested Capital (ROIC) | 14.45% |
| Return on Capital Employed (ROCE) | 4.83% |
| Weighted Average Cost of Capital (WACC) | 7.55% |
| Revenue Per Employee | 1.41M |
| Profits Per Employee | 267,876 |
| Employee Count | 428 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 2.82 |
Taxes
In the past 12 months, SHE:301393 has paid 18.43 million in taxes.
| Income Tax | 18.43M |
| Effective Tax Rate | 14.25% |
Stock Price Statistics
The stock price has increased by +32.65% in the last 52 weeks. The beta is 0.61, so SHE:301393's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +32.65% |
| 50-Day Moving Average | 51.86 |
| 200-Day Moving Average | 53.36 |
| Relative Strength Index (RSI) | 64.32 |
| Average Volume (20 Days) | 2,597,661 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301393 had revenue of CNY 602.26 million and earned 114.65 million in profits. Earnings per share was 1.07.
| Revenue | 602.26M |
| Gross Profit | 209.75M |
| Operating Income | 116.64M |
| Pretax Income | 129.27M |
| Net Income | 114.65M |
| EBITDA | 152.74M |
| EBIT | 116.64M |
| Earnings Per Share (EPS) | 1.07 |
Balance Sheet
The company has 1.31 billion in cash and 51.33 million in debt, with a net cash position of 1.26 billion or 11.77 per share.
| Cash & Cash Equivalents | 1.31B |
| Total Debt | 51.33M |
| Net Cash | 1.26B |
| Net Cash Per Share | 11.77 |
| Equity (Book Value) | 2.36B |
| Book Value Per Share | 21.65 |
| Working Capital | 1.45B |
Cash Flow
In the last 12 months, operating cash flow was 77.67 million and capital expenditures -210.63 million, giving a free cash flow of -132.96 million.
| Operating Cash Flow | 77.67M |
| Capital Expenditures | -210.63M |
| Depreciation & Amortization | 22.27M |
| Net Borrowing | -123.30M |
| Free Cash Flow | -132.96M |
| FCF Per Share | -1.24 |
Margins
Gross margin is 34.83%, with operating and profit margins of 19.37% and 19.04%.
| Gross Margin | 34.83% |
| Operating Margin | 19.37% |
| Pretax Margin | 21.46% |
| Profit Margin | 19.04% |
| EBITDA Margin | 25.36% |
| EBIT Margin | 19.37% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.67%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.67% |
| Dividend Growth (YoY) | 6.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 37.89% |
| Buyback Yield | 0.76% |
| Shareholder Yield | 1.43% |
| Earnings Yield | 1.83% |
| FCF Yield | -2.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |